DNAprint Genomics (DNAG)

[frogdreaming]

The evidence that exists is:

DNAP capitalized value = $10 Million (or less)
Biofrontera aquisition requires = $25 Million (or more)
Dutchess providing $35 Million in exchange for shares.
Number of shares available = less than 500 Million.
Number of Authorized shares = 1.5 Billion.

pps = 1 cent (or less)

The conclusion built on this factual evidence is that it is impossible to complete this transaction.

Common sense.

Explain another scenario that allows for the completion of this deal that does not require the participation of an 'imaginary' factor.

Good Luck